Filing Digest
Sep 14
Contineum Therapeutics Inc. (CTNM) has announced the results of its Phase 2 MOONLIGHT-1 trial, which evaluated the efficacy of JNJ-5120 (also known as PIPE-307) in patients with ch…
Filing Digest
Sep 14
Epic Games, the developer behind the popular game Fortnite, has seen its private market valuation decline significantly in recent months. According to data from Forge Global, the c…
Filing Digest
Sep 14
Former President Donald Trump has characterized the current backlash against artificial intelligence and data centers as a "SICK conspiracy." In a statement released on Monday, Tru…
Filing Digest
Sep 14
Merck & Co. Inc. (MRK) executives addressed potential changes to the 340B Drug Pricing Program and broader policy shifts during a presentation at the Morgan Stanley Healthcare Conf…
Filing Digest
Sep 14
ASML Holding N.V. (NASDAQ: ASML) is planning to increase production of its extreme-ultraviolet (EUV) chip-printing machines to over 110 units in 2028, according to a report from JP…
Filing Digest
Sep 14
Revere Asset Management, Inc. has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity securities portfolio as of the close of business on June 30…
Filing Digest
Sep 14
Rainmaker Worldwide Inc. has ended its interim executive leadership arrangement and appointed new directors and officers. On September 10, 2026, the company entered into a Terminat…
Filing Digest
Sep 14
QVC Group, Inc. has filed a monthly operating report with the United States Bankruptcy Court for the Southern District of Texas covering the period ending July 31, 2026. The filing…
Filing Digest
Sep 14
Moleculin Biotech, Inc. (Nasdaq: MBRX) announced on September 14, 2026, that new data regarding its lead drug candidate, Annamycin (naxtarubicin), will be presented at three scient…
Filing Digest
Sep 14
Niki BioSolutions, Inc. filed a Current Report on Form 8-K dated September 14, 2026, to disclose a corporate presentation. The document outlines the completion of a business combin…
Filing Digest
Sep 14
Kairos Pharma, Ltd. filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission on September 14, 2026. The filing discloses that the company issued a new in…
Filing Digest
Sep 14
On September 10, 2026, Yarrow Bioscience, Inc. entered into an underwriting agreement with Jefferies LLC, TD Securities (USA) LLC, and Guggenheim Securities, LLC to issue and sell …
Filing Digest
Sep 14
Emergent BioSolutions Inc. filed a Current Report on Form 8-K on September 14, 2026, announcing that President and Chief Executive Officer Joseph C. Papa will present at the H.C. W…
Filing Digest
Sep 14
Inmune Bio, Inc. (NASDAQ: INMB) announced on September 8, 2026, that its Board of Directors approved an increase in the number of directors, setting the total to seven. The company…
Filing Digest
Sep 14
Parker-Hannifin Corporation announced on September 14, 2026, that it has successfully completed a registered public offering of senior notes. The total offering size consists of $2…
Filing Digest
Sep 14
Veracyte, Inc. (VCYT) has entered into a definitive agreement to acquire Convergent Genomics, a genomic diagnostics company focused on bladder cancer. The transaction was executed …
Filing Digest
Sep 14
Contineum Therapeutics, Inc. (NASDAQ: CTNM) announced on September 14, 2026, that the Phase 2 MOONLIGHT-1 clinical trial for JNJ-5120/PIPE-307 did not achieve its primary efficacy …
Filing Digest
Sep 14
Boot Barn Holdings, Inc. (NYSE: BOOT) announced on September 14, 2026, its participation in two upcoming investor conferences and provided an update on its second fiscal quarter pe…
Filing Digest
Sep 14
PDS Biotechnology Corporation announced the initial closing of a private investment in public equity (PIPE) transaction on September 14, 2026, with gross proceeds of approximately …
Filing Digest
Sep 14
UK banks are reportedly launching a fundraising initiative with the stated goal of creating a new payments giant. According to the report, the financial institutions are coordinati…